Home Moderna

Moderna

In operation
Post-IPO Round
mRNA Therapeutics Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Moderna, Inc. was founded in 2010 and is an emerging company in the biotechnology field. The company is committed to treating infectious diseases, cancer, rare diseases, cardiovascular diseases, and more through mRNA therapies. mRNA is a set of instructions used by cells in the body to make proteins that prevent or fight diseases. Cells use these instructions to produce proteins and deliver them to various parts of the body. Moderna's corporate vision is to bring 100 drugs into clinical trials over the next decade for the treatment of all kinds of diseases – from cancer to rare genetic disorders.
Moderna, Inc.
Cambridge,Massachusetts,United States of America
more than 500 people
July 01, 2010
info@modernatx.com

Enterprise Profile

Industrial Sector
Biomanufacturing New Drug Development Production of Genetically Engineered Drugs
Technology
Gene Technology Biotechnology
Concept
Tumor Rare Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Prescription Drug Nucleic Acid Drugs